Explore All 557 Venture Life Science Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | May 22, 2018 |
| Target | Sublimity Therapeutics |
| Sector | Life Science |
| Investor(s) | HBM Partners |
| Deal Type | Venture |
FILTER BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 2.1B USD |
| Size | Large |
| Type | Sector Focused |
HBM Partners is a private investment firm focused on investing in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. HBM looks to invest $5 to $50 million per transaction and will consider private and public companies. HBM Partners was established in 2001 and is headquartered in Zug, Switzerland.
| Deal Context for Investor | # |
|---|---|
| Overall | 19 of 66 |
| Sector: Life Science | 15 of 56 |
| Type: Venture | 13 of 52 |
| Country: Ireland | 1 of 1 |
| Year: 2018 | 1 of 8 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-12-11 |
Hookipa
New York, New York, United States Hookipa is a clinical stage biotech company aiming to develop best-in-class active immunization therapies for infectious diseases and oncology. Hookipa was founded in 2011 and is based in New York, New York. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-06-25 |
Aptinyx
Evanston, Illinois, United States Aptinyx is a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. Aptinyx was founded in 2015 and is based in Evanston, Illinois. |
Sell | - |
